Imatinib Mesylate CAS 220127-57-1 Assay 98.0%~102.0% Ph+CML API Factory High Quality

Nkọwa dị mkpirikpi:

Aha kemịkal: Imatinib Mesylate (ụdị alpha)

Ọnọdụ: 220127-57-1

Ọdịdị: White ka Gbanyụọ-White Crystalline ntụ ntụ

Nyocha HPLC: 98.0% ~ 102.0%

Imatinib Mesylate na ọgwụgwọ nke Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+CML)

API Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com


Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Njirimara kemịkalụ:

Aha Chemical Imatinib Mesylate (ụdị alfa)
Ụdị okwu Imatinib methanesulfonate;STI571 Mesylate;CGP-57148B
Nọmba CAS 220127-57-1
Nọmba CAT RF-API19
Ọnọdụ Ahịa N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi C30H35N7O4S
Ibu molekụla 589.71
Ọnọdụ mbupu N'okpuru ọnọdụ okpomọkụ
Ụdị Ruifu Chemical

Nkọwapụta:

Ihe Nkọwapụta
Ọdịdị Ntụ ntụ kristal na-acha ọcha ruo na-agbanyụọ
Solubility Ọ dị mfe igbari na mmiri
HPLC njirimara Oge njigide kacha elu nke ụdịdị dị iche iche dabara na nke ahụ
Nchọpụta IR Infrared absorption ụdịdị dị iche iche nke sample kwekọrọ na ntụnyere sample
Ebe Na-agbaze 214.0 ~ 222.0 ℃
Ọnwụ na ihicha ≤0.50%
Ihe fọdụrụ na mgbanye ≤0.10%
Ọla dị arọ ≤20ppm
Ihe ndị emetụtara (1) adịghị ọcha G: NMT 0.3%
(2) adịghị ọcha B: NMT 0.3%
(3) adịghị ọcha C: NMT 0.3%
(4) adịghị ọcha D: NMT 0.3%
(5) adịghị ọcha A: NMT 0.3%
(6) adịghị ọcha H: NMT 0.3%
(7) adịghị ọcha F: NMT 0.3%
(8) adịghị ọcha E: NMT 0.3%
(9) Nnukwu otu adịghị ọcha: NMT0.1%
Ihe mgbaze fọdụrụnụ (1) Ethyl Acetate: NMT 5000ppm
(2) methanol: NMT3000ppm
(3) Dichloromethane: NMT 600ppm
(4) Ethanol: NMT 5000ppm
(5) Toluene: NMT 890ppm
(6) Dimethyl Sulfoxide: NMT5000ppm
HPLC nyocha 98.0% ~ 102.0% (C30H35N7SO4 gbakọrọ na Anhydrous ndabere)
Nlele ọkọlọtọ Standardkpụrụ ụlọ ọrụ
Ojiji API;Ph+CML

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.

Uru:

1

Ajụjụ:

Ngwa:

Imatinib Mesylate (CAS 220127-57-1) bụ obere molekul na-egbochi c-Abl protein-tyrosine kinase, kinase nke dị mkpa maka mmụba nke leukemia myelogenous na-adịghị ala ala (CML).Nke a kapịrị ọnụ maka BCR-ABL, enzyme jikọtara ya na ọrịa leukemia myelogenous na-adịghị ala ala (CML) na ụdị ụfọdụ nke nnukwu ọrịa leukemia lymphoblastic (ALL).Ọ bụ v-Abl tyrosine kinase inhibitor nke nwere ike na nhọrọ (IC50 = 38 nM).Ihe omume ntụgharị n'etiti chromosomes 9 na 22 na-emepụta chromosome Philadelphia, nke na-emepụta protein Bcr-Able fusion na ọrụ kinase aberrant nke na-akwalite mgbasawanye cell ngwa ngwa.Imatinib mesylate na-ejikọta kinase a dị mkpa, na-akwụsị uto metụtara CML.Imatinib mesylate ka egosiputala iji gbochie PDGFR na tyrosine kinases jikọtara ya na c-Kit.

Dee ozi gị ebe a ziga anyị ya